Nuvation Bio (NUVB) shares climbed by more than 43% in recent trading on Wednesday after B. Riley initiated coverage of the biopharmaceutical firm with a buy rating and a price target of $12.
Trading volume topped 27.5 million shares against a daily average of around 7.6 million.
Nuvation Bio shares were recently 43.1% higher at $6.87.
Price: 6.92, Change: +2.12, Percent Change: +44.06